208 related articles for article (PubMed ID: 9517380)
1. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice.
Su MT; Lin WB; Lue WM; Cheng CY; Tao PL
Br J Pharmacol; 1998 Feb; 123(4):625-30. PubMed ID: 9517380
[TBL] [Abstract][Full Text] [Related]
2. The role of nitric oxide in the development of morphine tolerance in rat hippocampal slices.
Lue WM; Su MT; Lin WB; Tao PL
Eur J Pharmacol; 1999 Oct; 383(2):129-35. PubMed ID: 10585526
[TBL] [Abstract][Full Text] [Related]
3. Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat.
Dunbar SA; Pulai IJ
J Pharmacol Exp Ther; 1998 Feb; 284(2):678-86. PubMed ID: 9454814
[TBL] [Abstract][Full Text] [Related]
4. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
5. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
6. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
8. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference.
Zarrindast MR; Lashgari R; Rezayof A; Motamedi F; Nazari-Serenjeh F
Eur J Pharmacol; 2007 Jul; 568(1-3):192-8. PubMed ID: 17509561
[TBL] [Abstract][Full Text] [Related]
9. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
Dziedzicka-Wasylewska M; Przewłocki R
Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
[TBL] [Abstract][Full Text] [Related]
10. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
11. Modulation of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY274614: assessment of opioid receptor changes.
Tiseo PJ; Cheng J; Pasternak GW; Inturrisi CE
J Pharmacol Exp Ther; 1994 Jan; 268(1):195-201. PubMed ID: 8301558
[TBL] [Abstract][Full Text] [Related]
12. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
Priestley T; Marshall GR; Hill RG; Kemp JA
Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
[TBL] [Abstract][Full Text] [Related]
13. The comparison of effects of processed Aconiti tuber, U50488H and MK-801 on the antinociceptive tolerance to morphine.
Shu H; Hayashida M; Huang W; An K; Chiba S; Hanaoka K; Arita H
J Ethnopharmacol; 2008 Apr; 117(1):158-65. PubMed ID: 18328652
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of N-methyl-D-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine.
Alonzo NC; Bayer BM
J Pharmacol Exp Ther; 2003 Nov; 307(2):793-800. PubMed ID: 12966157
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
16. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
17. MK-801 prevents the increased NMDA-NR1 and NR2B subunits mRNA expression observed in the hippocampus of rats tolerant to diazepam.
Almirón RS; Pérez MF; Ramírez OA
Brain Res; 2004 May; 1008(1):54-60. PubMed ID: 15081382
[TBL] [Abstract][Full Text] [Related]
18. Modification of the binding of [3H]MK-801 to brain regions and spinal cord of rats treated chronically with U-50,488H, a kappa-opioid receptor agonist.
Bhargava HN; Kumar S
Brain Res; 1997 Feb; 749(2):347-50. PubMed ID: 9138737
[TBL] [Abstract][Full Text] [Related]
19. Anteroventral third ventricular N-methyl-D-aspartate receptors, but not metabotropic glutamate receptors are involved in hemorrhagic AVP secretion.
Yamaguchi K; Watanabe K
Brain Res Bull; 2005 Jul; 66(1):59-69. PubMed ID: 15925145
[TBL] [Abstract][Full Text] [Related]
20. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment.
Hamabe W; Yamane H; Harada S; Tokuyama S
J Pharm Pharmacol; 2008 Sep; 60(9):1183-8. PubMed ID: 18718122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]